118 related articles for article (PubMed ID: 32163271)
1. Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors.
Yamanaka K; Takahashi Y; Azuma Y; Hantani Y
Biochemistry; 2020 Mar; 59(12):1242-1251. PubMed ID: 32163271
[TBL] [Abstract][Full Text] [Related]
2. Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice.
Inamori KI; Ito H; Tamura Y; Nitta T; Yang X; Nihei W; Shishido F; Imazu S; Tsukita S; Yamada T; Katagiri H; Inokuchi JI
J Lipid Res; 2018 Aug; 59(8):1472-1481. PubMed ID: 29880531
[TBL] [Abstract][Full Text] [Related]
3. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown.
Randeria PS; Seeger MA; Wang XQ; Wilson H; Shipp D; Mirkin CA; Paller AS
Proc Natl Acad Sci U S A; 2015 May; 112(18):5573-8. PubMed ID: 25902507
[TBL] [Abstract][Full Text] [Related]
4. Sialyltransferase Activity Assay for Ganglioside GM3 Synthase.
Inamori KI; Nitta T; Shishido F; Watanabe S; Ohno I; Inokuchi JI
Methods Mol Biol; 2023; 2613():101-110. PubMed ID: 36587074
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors.
Wang XQ; Lee S; Wilson H; Seeger M; Iordanov H; Gatla N; Whittington A; Bach D; Lu JY; Paller AS
J Invest Dermatol; 2014 May; 134(5):1446-1455. PubMed ID: 24326453
[TBL] [Abstract][Full Text] [Related]
6. Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts.
Shevchuk NA; Hathout Y; Epifano O; Su Y; Liu Y; Sutherland M; Ladisch S
Biochim Biophys Acta; 2007 Sep; 1771(9):1226-34. PubMed ID: 17604219
[TBL] [Abstract][Full Text] [Related]
7. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3.
Nagafuku M; Sato T; Sato S; Shimizu K; Taira T; Inokuchi J
Glycobiology; 2015 Mar; 25(3):303-18. PubMed ID: 25303960
[TBL] [Abstract][Full Text] [Related]
8. Biology of GM3 Ganglioside.
Inokuchi JI; Inamori KI; Kabayama K; Nagafuku M; Uemura S; Go S; Suzuki A; Ohno I; Kanoh H; Shishido F
Prog Mol Biol Transl Sci; 2018; 156():151-195. PubMed ID: 29747813
[TBL] [Abstract][Full Text] [Related]
9. [The regulation of ganglioside GM3 synthesis].
Uemura S
Yakugaku Zasshi; 2012; 132(8):895-901. PubMed ID: 22864347
[TBL] [Abstract][Full Text] [Related]
10. Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma.
Shimizu T; Nagane M; Suzuki M; Yamauchi A; Kato K; Kawashima N; Nemoto Y; Maruo T; Kawakami Y; Yamashita T
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129723. PubMed ID: 32861756
[TBL] [Abstract][Full Text] [Related]
11. GM3 synthase deficiency increases brain glucose metabolism in mice.
Bharathi SS; Zhang BB; Paul E; Zhang Y; Schmidt AV; Fowler B; Wu Y; Tiemeyer M; Inamori KI; Inokuchi JI; Goetzman ES
Mol Genet Metab; 2022 Dec; 137(4):342-348. PubMed ID: 36335793
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.
Inamori KI; Inokuchi JI
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628171
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM3 deficiency enhances mast cell sensitivity.
Komuro M; Mizugaki H; Nagane M; Morimoto M; Fukuyama T; Ogihara K; Naya Y; Yokomori E; Kaneshima K; Kawakami Y; Kamiie J; Shibata Y; Suzuki M; Shimizu T; Kawashima N; Okamoto M; Ikeda T; Yamashita T
FEBS J; 2023 Sep; 290(17):4268-4280. PubMed ID: 37098812
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).
Shishido F; Uemura S; Nitta T; Inokuchi JI
Glycoconj J; 2017 Oct; 34(5):651-659. PubMed ID: 28808804
[TBL] [Abstract][Full Text] [Related]
15. Enhanced insulin sensitivity in mice lacking ganglioside GM3.
Yamashita T; Hashiramoto A; Haluzik M; Mizukami H; Beck S; Norton A; Kono M; Tsuji S; Daniotti JL; Werth N; Sandhoff R; Sandhoff K; Proia RL
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3445-9. PubMed ID: 12629211
[TBL] [Abstract][Full Text] [Related]
16. Special considerations in the purification of the GM3 ganglioside forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): solubilization of SAT-1 with lauryldimethylamine oxide.
Melkerson-Watson LJ; Sweeley CC
Biochem Biophys Res Commun; 1990 Oct; 172(1):165-71. PubMed ID: 2222467
[TBL] [Abstract][Full Text] [Related]
17. Activation of ganglioside GM3 biosynthesis in human monocyte/macrophages during culturing in vitro.
Gracheva EV; Samovilova NN; Golovanova NK; Andreeva ER; Andrianova IV; Tararak EM; Prokazova NV
Biochemistry (Mosc); 2007 Jul; 72(7):772-7. PubMed ID: 17680770
[TBL] [Abstract][Full Text] [Related]
18. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion.
Allende ML; Li J; Darling DS; Worth CA; Young WW
Glycobiology; 2000 Oct; 10(10):1025-32. PubMed ID: 11030748
[TBL] [Abstract][Full Text] [Related]
19. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
Miura Y; Kainuma M; Jiang H; Velasco H; Vogt PK; Hakomori S
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16204-9. PubMed ID: 15534203
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility.
Dam DHM; Wang XQ; Sheu S; Vijay M; Shipp D; Miller L; Paller AS
J Invest Dermatol; 2017 Feb; 137(2):440-448. PubMed ID: 27729281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
